Indoline compound
Grant
US12577246B2
Kind: B2
Mar 17, 2026
Assignee
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Inventors
Jianyu Lu, Charles Z. Ding, Huijun He, Lihong Hu, Yuanyuan Huang, Jian Li, Shuhui Chen
Abstract
An indoline compound. Specifically disclosed is an application of a compound represented by formula (I) and pharmaceutically acceptable salts thereof in the preparation of drugs for treating related diseases.
CPC Classifications
C07D 471/04
C07D 519/00
C07D 498/04
C07D 513/04
A61P 35/00
A61K 31/44
A61K 31/519
Filing Date
2022-02-08
Application No.
18275457
Claims
19